The following statement was issued this afternoon by PCPC3 — the patient-centered prostate cancer collaborative coalition: PCPC3 and its members are extremely pleased to learn that a key advisory group to Medicare has recommended that the Centers for Medicare & Medicaid Services (CMS) step back from a proposal, initially put forward late in 2015, to […]![]()
